These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3501335)

  • 1. Anti-mycoplasmal activity of a new macrolide: miocamycin.
    Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
    Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
    Rylander M; Hallander HO
    Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro sensitivity to antibiotics of genital mycoplasmas isolated in Toulouse. Study of new molecules (macrolides and quinolones)].
    Bauriaud R; Séror C; Lareng MB; Lefèvre JC
    Pathol Biol (Paris); 1992 May; 40(5):479-82. PubMed ID: 1495830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activities of tetracyclines, macrolides, fluoroquinolones and clindamycin against Mycoplasma hominis and Ureaplasma ssp. isolated in Germany over 20 years.
    Krausse R; Schubert S
    Clin Microbiol Infect; 2010 Nov; 16(11):1649-55. PubMed ID: 20047607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
    Bebear C; Cantet P; Renaudin H; Quentin C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
    Waites KB; Cassell GH; Canupp KC; Fernandes PB
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimycoplasmal activities of (S)-(-)-9-fluoro-2,3-dihydro-3-methyl-10 -[4-(2-pyridyl)-1-piperazinyl]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine -6-carboxylic acid (YH-6) in comparison with other antibiotics in vitro.
    Ye H; Wu JM; Yang YS; Ji RY; Chen KX
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1031-4. PubMed ID: 11270970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro activity of miocamycin compared with four other macrolides and with pristinamycin against Branhamella catarrhalis].
    Suermondt G; Denamur E; Fleuret A; Laurans G; Orfila J
    Pathol Biol (Paris); 1989 May; 37(5):386-9. PubMed ID: 2506513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of miokamycin (MOM) against Chlamydia trachomatis and mycoplasmas in vitro.
    Ridgway GL; Mumtaz G; Gabriel G; Oriel JD
    J Antimicrob Chemother; 1983 Nov; 12(5):511-4. PubMed ID: 6608516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antibacterial activity of a new macrolide, miokamycin. Results of a multicenter study].
    Soussy CJ; Thabaut A; Bismuth R; Morel C; Berthelot G; Chanal M; Derlot E
    Pathol Biol (Paris); 1989 May; 37(5):358-63. PubMed ID: 2674868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of rokitamycin and other macrolide antibiotics on Mycoplasma pneumoniae in L cells.
    Misu T; Arai S; Furukawa M; Yamamoto Y; Miyazaki T
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1843-5. PubMed ID: 3124740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro comparative study of RU 28965 against organisms from oral and vaginal flora.
    Romeo MA; Lo Bue AM; Chisari G; Gismondo MR; Nicoletti G
    G Batteriol Virol Immunol; 1986; 79(1-6):16-24. PubMed ID: 3500081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic sensitivity of Mycoplasma pathogenic for man].
    Quentin C; Cantet P; Renaudin H; Bebear C
    Pathol Biol (Paris); 1985 Mar; 33(3):205-12. PubMed ID: 3892448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro sensitivity to antibiotics in 178 strains of genital mycoplasma isolated from gynecology consultants in Dakar].
    Sow AI; Diallo Y; el Hadi AD; Samb A
    Bull Soc Pathol Exot; 2000 Feb; 93(1):6-7. PubMed ID: 10774483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrolide antibiotics M-4365 produced by Micromonospora. IV. Antimycoplasmal activity of antibiotic M-4365 G2 (de-epoxy rosamicin).
    Onta T; Maezawa I; Kinumaki A; Ohshima S; Yamaguchi T
    J Antibiot (Tokyo); 1981 Jun; 34(6):719-26. PubMed ID: 7275854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the Mycoplasma Plus and the SIR Mycoplasma kits for quantitative detection and antibiotic susceptibility testing of genital mycoplasma].
    Renaudin H; Bebear C
    Pathol Biol (Paris); 1990 May; 38(5):431-5. PubMed ID: 2195452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of fleroxacin (RO 23-6240) against Ureaplasma urealyticum and Mycoplasma hominis.
    Krausse R; Ullmann U
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):67-9. PubMed ID: 3132382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.